Optimal weight base for a weight-based heparin dosing protocol

American Journal of Health-System Pharmacy

Volumn 55, Issue 2, 1998, Pages 159-162

  Yee, William P ^a   Norton, Linda L ^b  

^a St Joseph's Medical Center Stockton   (United States)

^b UNIVERSITY OF THE PACIFIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN;

ARTICLE; BODY WEIGHT; BOLUS INJECTION; DOSE CALCULATION; DRUG INFUSION; FEMALE; HEPARINIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL;

EID: 0031937523     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/55.2.159     Document Type: Article

References (12)

1. Raschke RA, Reilly BM, Guidry JR et al. The weight-based heparin dosing nomogram compared with a standard care nomogram. Ann Intern Med. 1993; 119:874-81.
2. Reilly BM, Raschke R, Srinivas S et al. Intravenous heparin dosing: patterns and variations in internists' practices. J Gen Intern Med. 1993; 8:536-42.
3. Ellison MJ, Sawyer WT, Mills TC. Calculation of heparin dosage in a morbidly obese woman. Clin Pharm. 1989; 8:65-8.
4. Zimmerman CR, Skaar DJ, Boyle MJ et al. Individualized heparin dosage improves anticoagulation and may reduce hemorrhagic complications after coronary thrombolysis. Paper presented at ASHP Midyear Clinical Meeting. New Orleans, LA; 1991 Dec 11.
5. Kershaw B, White RH, Mungall D et al. Computer-assisted dosing of heparin. Arch Intern Med. 1994; 154:1005-11.
6. Holliday DM, Watling SM, Yanos J. Heparin dosing in the morbidly obese patient. Ann Pharmacother. 1994; 28:1110-1.
7. Joch LE, Lutomski DM, Williams DJ et al. Accuracy of a first-order model for estimating initial heparin dosage. Clin Pharm. 1993; 12:597-601.
8. Cipolle RJ, Uden DL, Gruber SA et al. Evaluation of a rapid monitoring system to study heparin pharmacokinetics and pharmacodynamics. Pharmacotherapy. 1990; 10:367-72.
9. Raschke R, Reilly B. Monitoring heparin therapy. Ann Intern Med. 1994; 120:169-70.
10. Hull RD, Raskob GE, Rosenbloom D et al. Optimal therapeutic level of heparin therapy in patients with venous thrombosis. Arch Intern Med. 1992; 152:1589-95.
11. Hull RD, Raskob GE, Hirsh J et al. Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis. N Engl J Med. 1986; 315:1109-14.
12. Granger CB, Hirsh J, Califf RM et al. Activated partial thromboplastin time and outcome after thrombolytic therapy for acute myocardial infarction. Results from the GUSTO-I trial, Circulation. 1996; 93:870-8.